Mesenchymal Stromal Stem Cell-Derived Microvesicles Enhance Tumor Lysate Pulsed Dendritic Cell Stimulated Autologous T lymphocyte Cytotoxicity
Conclusion: These findings may offer new insights into tumor antigen presenting technology involving
dendritic cells and MSC1-derived MVs. Further exploration of the potential of such nanoscale particles in immunotherapy
and in novel cancer vaccine settings appears warranted.
PMID: 30049202 [PubMed - in process]
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Cancer Vaccines | Glioma | Immunotherapy | Nanotechnology | Neurology | Stem Cell Therapy | Stem Cells | Study | Vaccines